Abstract
Dementia is a clinical syndrome that is characterized by impairment of cognitive and functional abilities (daily life activities) as well as by neuropsychiatric symptoms. Cognitive impairment can include impairment of memory, visuospatial functions, language, and executive functions. Many neurodegenerative diseases turn over to dementia, Alzheimer´s Disease being the most frequent of them. Alzheimer´s Disease (AD) affect a large population worldwide.
In the last decade, various medications have been used for the treatment of cognitive symptoms in AD. Many of them have few scientific evidence of their effectiveness. The aim of this paper is to review and update the current status of the pharmacological treatment of cognitive symptoms in Alzheimer´s Disease.
Keywords: Alzheimer's disease, cognitive symptoms, dementia, pharmacological treatment.
Current Psychopharmacology
Title:Pharmacological Treatment of Cognitive Symptoms in Alzheimer's Disease
Volume: 3
Author(s): Patricio Perez Leguizamon, Carol Dillon, Diego M. Castro, Leandro Lon, Veronica Guelar and Fernando E. Taragano
Affiliation:
Keywords: Alzheimer's disease, cognitive symptoms, dementia, pharmacological treatment.
Abstract: Dementia is a clinical syndrome that is characterized by impairment of cognitive and functional abilities (daily life activities) as well as by neuropsychiatric symptoms. Cognitive impairment can include impairment of memory, visuospatial functions, language, and executive functions. Many neurodegenerative diseases turn over to dementia, Alzheimer´s Disease being the most frequent of them. Alzheimer´s Disease (AD) affect a large population worldwide.
In the last decade, various medications have been used for the treatment of cognitive symptoms in AD. Many of them have few scientific evidence of their effectiveness. The aim of this paper is to review and update the current status of the pharmacological treatment of cognitive symptoms in Alzheimer´s Disease.
Export Options
About this article
Cite this article as:
Leguizamon Perez Patricio, Dillon Carol, Castro M. Diego, Lon Leandro, Guelar Veronica and Taragano E. Fernando, Pharmacological Treatment of Cognitive Symptoms in Alzheimer's Disease, Current Psychopharmacology 2014; 3 (1) . https://dx.doi.org/10.2174/2211556003666140717184049
DOI https://dx.doi.org/10.2174/2211556003666140717184049 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Insights into the Roles of Endolysosomal Cathepsins in the Pathogenesis of Alzheimers Disease: Cathepsin Inhibitors as Potential Therapeutics
CNS & Neurological Disorders - Drug Targets Angiotensin II Type I Receptor Blocker and Endothelial Function in Humans: Role of Nitric Oxide and Oxidative Stress
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander?
Current Pharmaceutical Design Dyslipidemia, Metabolic Syndrome and Vascular Disease Among Asian Indians
Vascular Disease Prevention (Discontinued) Conference Report (The XVth International Symposium of Brain Edema and Cellular Injury)
CNS & Neurological Disorders - Drug Targets Brain Adaptation to Stressful Stimuli: A New Perspective on Potential Therapeutic Approaches Based on BDNF and NMDA Receptors
CNS & Neurological Disorders - Drug Targets The Cell Cycle Molecules Behind Neurodegeneration in Alzheimers Disease: Perspectives for Drug Development
Current Medicinal Chemistry Patent Annotations
Recent Patents on Cardiovascular Drug Discovery Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders
Current Topics in Medicinal Chemistry Recent Patents on Epilepsy Genetics
Recent Patents on DNA & Gene Sequences Amyloid β Accumulation Assessed with <sup>11</sup>C-Pittsburgh Compound B PET and Postmortem Neuropathology
Current Alzheimer Research Gut Permeability and Microbiota in Parkinson’s Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways
Current Pharmaceutical Design The Role of IRE1 Signaling in the Central Nervous System Diseases
Current Neuropharmacology Proniosomes in Transdermal Drug Delivery
Current Pharmaceutical Design Targeting Striatal Metabotropic Glutamate Receptor Type 5 in Parkinson’s Disease: Bridging Molecular Studies and Clinical Trials
CNS & Neurological Disorders - Drug Targets Quantitative Electroencephalogram Analysis in Parkinson’s Disease
Neuroscience and Biomedical Engineering (Discontinued) Electrochemistry of Alzheimer Disease Amyloid Beta Peptides
Current Medicinal Chemistry Advances in Bioconjugation
Current Organic Chemistry A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects
Current Neuropharmacology Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Current Pharmaceutical Design